12/17/2024
4:21 PM | Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024
3:28 PM | Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024
3:28 PM | Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
3:31 PM | Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2024
4:28 PM | Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
10:38 AM | Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
3:25 PM | Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
09/25/2024
5:29 PM | Godwin Mary E. (Reporting)
Nautilus Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
3:58 PM | Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
5:32 PM | Godwin Mary E. (Reporting)
Nautilus Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:40 PM | Nautilus Biotechnology (Issuer)
Suzuki Kentaro (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/17/2024
3:47 PM | Nautilus Biotechnology (Issuer)
Suzuki Kentaro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:22 PM | Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
5:02 PM | EDELMAN JOSEPH (Reporting)
Nautilus Biotechnology (Issuer)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
5:03 PM | ALTMAN MICHAEL SETH (Reporting)
Nautilus Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
5:09 PM | McIlwain Matthew S (Reporting)
Nautilus Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:37 PM | Epperly Melissa B, (Reporting)
Nautilus Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:40 PM | Akinsanya Karen (Reporting)
Nautilus Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:24 PM | Nautilus Biotechnology (Issuer)
NAZEM FARZAD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:35 PM | Nautilus Biotechnology (Issuer)
Pande Vijay Satyanand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2024
3:12 PM | Nautilus Biotechnology (Filer)
| Form ARS | |
03/11/2024
7:21 PM | Nautilus Biotechnology (Issuer)
Patel Sujal M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
6:06 PM | Nautilus Biotechnology (Issuer)
Patel Sujal M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
11:15 PM | Nautilus Biotechnology (Filer)
| Form EFFECT | |
03/05/2024
3:52 PM | Nautilus Biotechnology (Issuer)
Patel Sujal M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:42 PM | Mowry Anna (Reporting)
Nautilus Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:25 AM | Nautilus Biotechnology (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/28/2024
6:26 AM | Nautilus Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
6:15 AM | Nautilus Biotechnology (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2024
6:03 AM | Nautilus Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
6:04 AM | Nautilus Biotechnology (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
